02/20
Headlines

NASDAQ:OMED

Why Need to Watch : Hewlett-Packard (NYSE:HPQ), Sonus Networks (NASDAQ:SONS), Rock Creek Pharmaceuticals (NASDAQ:RCPI), OncoMed Pharmaceuticals (NASDAQ:OMED), Lamar Advertising. (NASDAQ:LAMR)

Kristen Barton03 mins

Hewlett-Packard Company (NYSE:HPQ) has just expanded its HP Helion portfolio with the launch of a new, low-cost virtual private cloud offering. Called HP Helion Virtual Private Cloud (VPC) Lean, the new infrastructure-as-a-service product touts enhanced workload performance and better service delivery at a significantly reduced cost compared to HP’s other cloud services. Hewlett-Packard Company (NYSE:HPQ)…

Read More

Watch List: American Diversified Holdings (OTCMKTS:ADHC), Oncomed Pharmaceuticals (NASDAQ:OMED), Concert Pharmaceuticals (NASDAQ:CNCE), Actinium Pharmaceuticals (NYSEMKT:ATNM)

Richard Atkins02 mins

American Diversified Holdings Corp (OTCMKTS:ADHC) stock performance was -16.67% in last session and finished the day at $0.0375. Traded volume was 506,482.00million shares in the last session. The beta of the stock remained 3.20. OncoMed Pharmaceuticals Inc said it halted patient enrollment and dosing in all ongoing early-stage trials of two of its experimental cancer…

Read More

Small Cap Losers: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Altisource Asset Management (NYSEMKT:AAMC), Oncomed Pharmaceuticals (NASDAQ:OMED), Agios Pharmaceuticals (NASDAQ:AGIO)

John Meady02 mins

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from a Phase 1 study of the selective estrogen receptor modulator (SERM) lasofoxifene were featured in a poster presentation today at ICE/ENDO 2014 in Chicago.  Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) stock performance was -5.92% in last session and finished the day at $62.35. Traded volume was 400.60K shares…

Read More

Healthcare losers: Corcept Therapeutics Incorporated (NASDAQ:CORT), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Anika Therapeutics (NASDAQ:ANIK), Oncomed Pharmaceuticals (NASDAQ:OMED), Cesca Therapeutics (NASDAQ:KOOL)

Richard Atkins03 mins

Corcept Therapeutics Inc (NASDAQ:CORT) Director G Leonard Baker, Jr. bought 103,386 shares of the stock in a transaction that occurred on Wednesday, June 11th. The stock was purchased at an average cost of $2.32 per share, for a total transaction of $239,855.52. Following the completion of the transaction, the director now directly owns 578,389 shares…

Read More

Biotech bearish stocks: Prothena Corporation (NASDAQ:PRTA), Oncomed Pharmaceuticals (NASDAQ:OMED), Enanta Pharmaceuticals (NASDAQ:ENTA), Vanda Pharmaceuticals (NASDAQ:VNDA)

Colin Pettis02 mins

Shares of Prothena Corp PLC (NASDAQ:PRTA) were the recipient of a large increase in short interest in the month of January. As of March 14th, there was short interest totaling 824,645 shares, an increase of 35.0% from the February 28th total of 610,797 shares, AnalystRatingsNetwork.com reports. Prothena Corporation PLC (NASDAQ:PRTA) stock performance was -13.98% in…

Read More

Biotech Losers: Inovio Pharmaceuticals (NYSEMKT:INO), Oncomed Pharmaceuticals (NASDAQ:OMED), Enzymotec (NASDAQ:ENZY), Veracyte Inc (NASDAQ:VCYT)

Kristen Barton02 mins

Inovio Pharmaceuticals, Inc. (NYSEMKT:INO) announced financial results for the quarter and year ended December 31, 2013. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -7.98% in last session and finished the day at $3.23. Traded volume was 10,401,414 million shares in the last session and the average volume of the stock remained 7.79 million shares. The…

Read More